---
figid: PMC2696318__nihms28626f5
figtitle: ROLES OF THE RAF/MEK/ERK PATHWAY IN CELL GROWTH, MALIGNANT TRANSFORMATION
  AND DRUG RESISTANCE
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2696318
filename: nihms28626f5.jpg
figlink: /pmc/articles/PMC2696318/figure/F5/
number: F5
caption: This figure summarizes some of the complex interactions between p53 and the
  Raf/MEK/ERK and PI3K/Akt pathways. These pathways are linked by complex interactions
  both directly and indirectly. These interactions can result in regulation of cell
  cycle progression as well as apoptosis. Dotted lines indicate indirect pathways.
papertitle: ROLES OF THE RAF/MEK/ERK PATHWAY IN CELL GROWTH, MALIGNANT TRANSFORMATION
  AND DRUG RESISTANCE.
reftext: James A. McCubrey, et al. Biochim Biophys Acta. ;1773(8):1263-1284.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9062734
figid_alias: PMC2696318__F5
figtype: Figure
redirect_from: /figures/PMC2696318__F5
ndex: bc161356-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2696318__nihms28626f5.html
  '@type': Dataset
  description: This figure summarizes some of the complex interactions between p53
    and the Raf/MEK/ERK and PI3K/Akt pathways. These pathways are linked by complex
    interactions both directly and indirectly. These interactions can result in regulation
    of cell cycle progression as well as apoptosis. Dotted lines indicate indirect
    pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - mei-41
  - put
  - RYa-R
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - p53
  - betaTub60D
  - hth
  - Pdk
  - Pdk1
  - CycE
  - cyc
  - Akt
  - Raf
  - twe
  - stg
  - Cdk4
  - Go
  - Dsor1
  - Mtk
  - Cdk1
  - LanB2
  - anon-70Db
  - Erk7
  - rl
  - anon-70Dc
  - rb
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - wrd
  - wdb
  - mts
  - tws
  - Pp2A-29B
  - Cdk2
  - Ets21C
  - Ets65A
  - pnt
  - Ets96B
  - Ets97D
  - Ets98B
  - foxo
  - ebi
  - E2f2
  - E2f1
  - tRNA:Lys-TTT-1-1
  - tRNA:Lys-TTT-2-4
  - tRNA:Lys-TTT-2-1
  - tRNA:Lys-TTT-2-2
  - tRNA:Lys-TTT-2-5
  - tRNA:Lys-TTT-2-3
  - MDM2
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - HBEGF
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - TP53
  - TP63
  - TP73
  - CDKN1A
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - CDC25C
  - RASGRF1
  - CDC25A
  - CDC25B
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PMAIP1
  - BCL2L11
  - BBC3
  - MCL1
  - EPHB2
  - MAPK1
  - MAPK3
  - WARS1
  - DUSP1
  - ADCYAP1R1
  - KLF6
  - DUSP2
  - PSMG1
  - DUSP5
  - PTPA
  - ETS1
  - ETS2
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - APP
  - AAAS
  - AAA1
  - Cancer
  - Lung cancer
---
